BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36806643)

  • 1. Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study.
    Flora A; Kozera E; Frew JW
    J Am Acad Dermatol; 2023 Jul; 89(1):137-138. PubMed ID: 36806643
    [No Abstract]   [Full Text] [Related]  

  • 2. Janus kinase inhibitors for alopecia areata: A narrative review.
    Haughton RD; Herbert SM; Ji-Xu A; Downing L; Raychaudhuri SP; Maverakis E
    Indian J Dermatol Venereol Leprol; 2023; 89(6):799-806. PubMed ID: 37436019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Janus Kinase Inhibitors in the Treatment of Alopecia Areata.
    Stefanis AJ
    Prague Med Rep; 2023; 124(1):5-15. PubMed ID: 36763827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Janus kinase inhibitors for the treatment of alopecia areata].
    Kobal I; Ramot Y
    Hautarzt; 2022 May; 73(5):336-343. PubMed ID: 35482047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus kinase inhibitors for alopecia areata.
    King BA; Craiglow BG
    J Am Acad Dermatol; 2023 Aug; 89(2S):S29-S32. PubMed ID: 37591562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for alopecia areata: JAK inhibitors.
    Iorizzo M; Tosti A
    Expert Opin Emerg Drugs; 2018 Mar; 23(1):77-81. PubMed ID: 29466675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis.
    Barati Sedeh F; Michaelsdóttir TE; Henning MAS; Jemec GBE; Ibler KS
    Acta Derm Venereol; 2023 Jan; 103():adv00855. PubMed ID: 36695751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus kinase inhibitors: An innovative treatment for alopecia areata.
    Park H; Yu DA; Kwon O
    J Dermatol; 2019 Aug; 46(8):724-730. PubMed ID: 31237712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia areata: Recent advances and emerging therapies.
    Seneschal J; Boniface K; Jacquemin C
    Ann Dermatol Venereol; 2022 Dec; 149(4):222-227. PubMed ID: 35752494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
    Ramot Y; Zlotogorski A
    Harefuah; 2020 Jan; 159(1):38-42. PubMed ID: 31930807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Janus kinase inhibitors for the use of alopecia areata: A promising therapeutic of the future.
    Updyke KM
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29124830
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral Baricitinib Restores Hair Loss in Alopecia Areata.
    Slomski A
    JAMA; 2022 Jun; 327(24):2386. PubMed ID: 35762995
    [No Abstract]   [Full Text] [Related]  

  • 14. The Evolving Story of JAK Inhibitors for Treating Alopecia Areata: A Review of Current Progress and Future Directions.
    Donovan J
    Skin Therapy Lett; 2023 May; 28(3):1-7. PubMed ID: 37339501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results.
    King B; Guttman-Yassky E; Peeva E; Banerjee A; Sinclair R; Pavel AB; Zhu L; Cox LA; Craiglow B; Chen L; Banfield C; Page K; Zhang W; Vincent MS
    J Am Acad Dermatol; 2021 Aug; 85(2):379-387. PubMed ID: 33757798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata.
    Ramírez-Marín HA; Tosti A
    Drug Des Devel Ther; 2022; 16():363-374. PubMed ID: 35210753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
    Casale F; Yale K; Mesinkovska NA
    Int J Dermatol; 2022 Nov; 61(11):e457-e458. PubMed ID: 34716575
    [No Abstract]   [Full Text] [Related]  

  • 18. Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib.
    Fetter T; Rios GC; Niebel D; Bieber T; Wenzel J
    Acta Derm Venereol; 2020 May; 100(10):adv00144. PubMed ID: 32285135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based Review.
    Abduelmula A; Mufti A; Mistry J; Sachdeva M; Beecker J; Prajapati VH; Yeung J
    J Cutan Med Surg; 2023; 27(1):73-75. PubMed ID: 36189927
    [No Abstract]   [Full Text] [Related]  

  • 20. The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature.
    Crowley EL; Fine SC; Katipunan KK; Gooderham MJ
    J Cutan Med Surg; 2019; 23(3):289-297. PubMed ID: 30688081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.